208 related articles for article (PubMed ID: 12235276)
21. The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells.
Nilsson O; Fowler CJ; Jacobsson SO
Eur J Pharmacol; 2006 Oct; 547(1-3):165-73. PubMed ID: 16928371
[TBL] [Abstract][Full Text] [Related]
22. Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain.
Benamar K; Yondorf M; Geller EB; Eisenstein TK; Adler MW
Br J Pharmacol; 2009 Aug; 157(7):1225-31. PubMed ID: 19558543
[TBL] [Abstract][Full Text] [Related]
23. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
25. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
Shivachar AC
Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
[TBL] [Abstract][Full Text] [Related]
27. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
Landi M; Croci T; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Manara L
Eur J Pharmacol; 2002 Aug; 450(1):77-83. PubMed ID: 12176112
[TBL] [Abstract][Full Text] [Related]
28. Topical cannabinoid antinociception: synergy with spinal sites.
Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid modulation of intestinal propulsion in mice.
Colombo G; Agabio R; Lobina C; Reali R; Gessa GL
Eur J Pharmacol; 1998 Feb; 344(1):67-9. PubMed ID: 9570450
[TBL] [Abstract][Full Text] [Related]
30. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC
Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536
[TBL] [Abstract][Full Text] [Related]
31. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
[TBL] [Abstract][Full Text] [Related]
32. Intra-accumbal NMDA but not AMPA/kainate receptor antagonist attenuates WIN55,212-2 cannabinoid receptor agonist-induced antinociception in the basolateral amygdala in a rat model of acute pain.
Ghalandari-Shamami M; Hassanpour-Ezatti M; Haghparast A
Pharmacol Biochem Behav; 2011 Dec; 100(2):213-9. PubMed ID: 21924283
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells.
Takahashi KA; Linden DJ
J Neurophysiol; 2000 Mar; 83(3):1167-80. PubMed ID: 10712447
[TBL] [Abstract][Full Text] [Related]
35. Vasorelaxant effect of Win 55,212-2 in rat aorta: new mechanisms involved.
Dannert MT; Alsasua A; Herradon E; Martín MI; López-Miranda V
Vascul Pharmacol; 2007 Jan; 46(1):16-23. PubMed ID: 16860612
[TBL] [Abstract][Full Text] [Related]
36. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
Huang CC; Lo SW; Hsu KS
J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
38. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.
Chaperon F; Soubrié P; Puech AJ; Thiébot MH
Psychopharmacology (Berl); 1998 Feb; 135(4):324-32. PubMed ID: 9539255
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoids enhance N-methyl-D-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices.
Mendiguren A; Pineda J
Neurosci Lett; 2004 Jun; 363(1):1-5. PubMed ID: 15157983
[TBL] [Abstract][Full Text] [Related]
40. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
